• 
  Yanis Berkane, David M. Kostyra, Théodoros Chrelias, Mark A. Randolph, Alexandre G Lellouch, et al.. The Autonomization Principle in Vascularized Flaps: An Alternative Strategy for Composite Tissue Scaffold In Vivo Revascularization. Bioengineering, 2023, Bioengineering, 10 (12), pp.1440-1440. ⟨10.3390/bioengineering10121440⟩. ⟨hal-04358061⟩
• 
  Marion Haas, Gersende Caron, Fabrice Chatonnet, Stéphane Manenti, Elina Alaterre, et al.. PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma. Blood, 2022, 139 (15), pp.2316-2337. ⟨10.1182/blood.2021014011⟩. ⟨hal-04822853v2⟩
• 
  Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, et al.. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group. Blood Advances, 2023, 7 (14), pp.3735-3738. ⟨10.1182/bloodadvances.2023009911⟩. ⟨hal-04239554⟩
• 
  Camille Laurent, Sascha Dietrich, Karin Tarte. Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm. Blood, 2024, 143 (12), pp.1080-1090. ⟨10.1182/blood.2023021000⟩. ⟨inserm-04773407v2⟩
• 
  Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, et al.. Non-Relapse Mortality after CAR T-Cell therapy for Large B-Cell Lymphoma: A LYSA Study from the DESCAR-T Registry. Blood Advances, 2023, 7 (21), pp.6589-6598. ⟨10.1182/bloodadvances.2023010624⟩. ⟨hal-04244499⟩

321

311